Suppr超能文献

相似文献

1
A case of primary (AL) amyloidosis with predominantly vascular amyloid deposition in the kidney.
CEN Case Rep. 2015 Nov;4(2):151-156. doi: 10.1007/s13730-014-0157-7. Epub 2014 Dec 2.
2
The clinicopathological spectrum of renal amyloidosis.
Zhonghua Yi Xue Za Zhi (Taipei). 1994 Oct;54(4):230-9.
3
[Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Presse Med. 2012 Mar;41(3 Pt 1):276-89. doi: 10.1016/j.lpm.2011.11.008. Epub 2012 Jan 13.
4
Resolution of primary amyloidosis by melphalan and prednisolone: a case report.
Clin Nephrol. 2005 Mar;63(3):215-20. doi: 10.5414/cnp63215.
5
A rare lung nodule consisting of adenocarcinoma and amyloid deposition in a patient with primary systemic AL amyloidosis.
Intern Med. 2011;50(3):243-6. doi: 10.2169/internalmedicine.50.4094. Epub 2011 Feb 1.
8
Urinary findings in renal light chain-derived amyloidosis and light chain deposition disease.
Clin Lymphoma Myeloma. 2009 Jun;9(3):234-8. doi: 10.3816/CLM.2009.n.046.
9
A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
Nephrology (Carlton). 2004 Jun;9(3):122-5. doi: 10.1111/j.1440-1797.2004.00246.x.
10
[kappa-light chain amyloidosis of the liver, a rare cause of liver enzyme elevation].
Dtsch Med Wochenschr. 2008 May;133(21):1116-20. doi: 10.1055/s-2008-1077225.

引用本文的文献

1
Late evolution of an arteriovenous fistula in renal transplant: a case report.
BMC Nephrol. 2025 Jul 16;26(1):391. doi: 10.1186/s12882-025-04327-5.
2
On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications.
Front Immunol. 2020 Oct 2;11:571083. doi: 10.3389/fimmu.2020.571083. eCollection 2020.
4
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation.
J Nephrol. 2021 Feb;34(1):231-240. doi: 10.1007/s40620-020-00748-7. Epub 2020 May 29.

本文引用的文献

1
A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis.
Nephrol Dial Transplant. 2013 Mar;28(3):689-97. doi: 10.1093/ndt/gfs501. Epub 2012 Nov 25.
3
Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney.
Nephrol Dial Transplant. 2012 Mar;27(3):1097-101. doi: 10.1093/ndt/gfr381. Epub 2011 Nov 7.
5
Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis.
J Clin Oncol. 2010 Feb 20;28(6):1031-7. doi: 10.1200/JCO.2009.23.8220. Epub 2010 Jan 19.
6
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study.
Blood. 2009 Aug 20;114(8):1489-97. doi: 10.1182/blood-2009-02-203398. Epub 2009 Jun 4.
8
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.
Haematologica. 2008 Mar;93(3):459-62. doi: 10.3324/haematol.11687. Epub 2008 Feb 20.
10
Amyloidosis-associated kidney disease.
J Am Soc Nephrol. 2006 Dec;17(12):3458-71. doi: 10.1681/ASN.2006050460. Epub 2006 Nov 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验